These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 18458229

  • 1. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM, Gracies JM, Graham HK, Miyasaki JM, Naumann M, Russman B, Simpson LL, So Y, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology; 2008 May 06; 70(19):1691-8. PubMed ID: 18458229
    [Abstract] [Full Text] [Related]

  • 2. Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Naumann M, So Y, Argoff CE, Childers MK, Dykstra DD, Gronseth GS, Jabbari B, Kaufmann HC, Schurch B, Silberstein SD, Simpson DM, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology; 2008 May 06; 70(19):1707-14. PubMed ID: 18458231
    [Abstract] [Full Text] [Related]

  • 3. Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Simpson DM, Blitzer A, Brashear A, Comella C, Dubinsky R, Hallett M, Jankovic J, Karp B, Ludlow CL, Miyasaki JM, Naumann M, So Y, Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Neurology; 2008 May 06; 70(19):1699-706. PubMed ID: 18458230
    [Abstract] [Full Text] [Related]

  • 4. Evidence-based review and assessment of botulinum neurotoxin for the treatment of adult spasticity in the upper motor neuron syndrome.
    Esquenazi A, Albanese A, Chancellor MB, Elovic E, Segal KR, Simpson DM, Smith CP, Ward AB.
    Toxicon; 2013 Jun 01; 67():115-28. PubMed ID: 23220492
    [Abstract] [Full Text] [Related]

  • 5. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
    Simpson DM, Gracies JM, Graham K, Hallett M, Miyasaki J, Naumann M, Russman B, Simpson L, So Y.
    Neurology; 2009 Sep 01; 73(9):736-7; author reply 737-8. PubMed ID: 19728407
    [No Abstract] [Full Text] [Related]

  • 6. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review).
    Dobkin BH, Landau WM, Sahrmann S, Thomas Thach W, Simpson DM, Gracies JM, Graham K, Hallett M, Miyasaki J, Naumann M, Russman B, Simpson L, So Y.
    Neurology; 2009 Sep 01; 73(9):736; author reply 737-8. PubMed ID: 19720984
    [No Abstract] [Full Text] [Related]

  • 7. Botulinum Toxin Treatment of Spasticity in Adults and Children.
    Moeini-Naghani I, Hashemi-Zonouz T, Jabbari B.
    Semin Neurol; 2016 Feb 01; 36(1):64-72. PubMed ID: 26866498
    [Abstract] [Full Text] [Related]

  • 8. [Use of botulinum neurotoxin for spasticity].
    Mukai Y, Kaji R.
    Brain Nerve; 2008 Dec 01; 60(12):1421-6. PubMed ID: 19110753
    [Abstract] [Full Text] [Related]

  • 9. Botulinum toxin for the management of adult patients with upper motor neuron syndrome.
    Esquenazi A, Mayer NH, Elia AE, Albanese A.
    Toxicon; 2009 Oct 01; 54(5):634-8. PubMed ID: 19470335
    [Abstract] [Full Text] [Related]

  • 10. Clinical trials of botulinum toxin in the treatment of spasticity.
    Simpson DM.
    Muscle Nerve Suppl; 1997 Oct 01; 6():S169-75. PubMed ID: 9826988
    [Abstract] [Full Text] [Related]

  • 11. [Spasticity and botulinum toxin in 2003. An update].
    Fève A.
    Neurochirurgie; 2003 May 01; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
    [Abstract] [Full Text] [Related]

  • 12. Clinical comparisons of botulinum neurotoxin formulations.
    Brashear A.
    Neurologist; 2008 Sep 01; 14(5):289-98. PubMed ID: 18784598
    [Abstract] [Full Text] [Related]

  • 13. Practice parameter: pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review): report of the quality standards subcommittee of the american academy of neurology and the practice committee of the child neurology society.
    Whelan MA, Delgado MR.
    Neurology; 2010 Aug 17; 75(7):669. PubMed ID: 20713958
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High doses of botulinum toxin effectively treat disabling up-going toe.
    Kurtis MM, Floyd AG, Yu QP, Pullman SL.
    J Neurol Sci; 2008 Jan 15; 264(1-2):118-20. PubMed ID: 17884097
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evidence-based review and assessment of botulinum neurotoxin for the treatment of urologic conditions.
    Chancellor MB, Elovic E, Esquenazi A, Naumann M, Segal KR, Schiavo G, Smith CP, Ward AB.
    Toxicon; 2013 Jun 01; 67():129-40. PubMed ID: 23415704
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE, Racette BA.
    Pediatr Neurol; 2008 Oct 01; 39(4):253-8. PubMed ID: 18805363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.